Found: 3
Select item for more details and to access through your institution.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1866, doi. 10.1177/1352458519888610
- By:
- Publication type:
- Article
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 48, doi. 10.1177/1352458518816612
- By:
- Publication type:
- Article
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 9, p. 1273, doi. 10.1177/1352458519841829
- By:
- Publication type:
- Article